Navigation Links
Hillary Clinton Released From NYC Hospital
Date:1/3/2013

WEDNESDAY, Jan. 2 (HealthDay News) -- Secretary of State Hillary Clinton was released from a New York hospital Wednesday evening following treatment for a blood clot in her head.

Clinton's doctors at NewYork-Presbyterian Hospital treated the clot -- which they believe is linked to a concussion she suffered in December -- with blood-thinning medication.

Clinton spokesman Philippe Reines said her doctors said she has been making steady progress and are confident she will make a full recovery, the Associated Press reported.

The clot was located outside of the brain, in a vein in the space between the brain and the skull behind the 65-year-old Clinton's right ear. The general term for the condition is called cerebral venous thrombosis. Clinton's doctors reported that she did not experience any stroke or neurological injury from the clot.

One expert noted that Clinton will need to be careful in the coming weeks.

"The vast majority of venus sinus thrombosis do not have severe symptoms, and are treated with a combination of hydration and anti-coagulants [blood thinners], which cause the thrombosis [clot] to slowly dissolve," said Dr. Anders Cohen, chief of neurosurgery and spine surgery at The Brooklyn Hospital Center. "It's important that she gets rest and hydration. Because she'll likely be on blood thinners, she'll have to be careful to avoid falls, which could cause significant bleeding.

"The duration of this medication depends on the size of the thrombosis and Mrs. Clinton's clinical status," Cohen added. "Unless she has a hematological condition that predisposes her to [clots], it is unlikely to reoccur. Most likely, the condition was due to her extremely hectic travel schedule. As a result of the travel, she probably suffered from chronic dehydration, which probably led to her fainting episode last month and caused this thrombosis."

Clinton was first admitted to the hospital late Sunday after doctors discovered the clot during a regular follow-up exam, Reines said.

She canceled most of her public events over the past few weeks because of the head injury.

Doctors not involved in Clinton's care said blood thinners are typically used to dissolve clots, and patients may need to be on them for weeks or months.

"Therapy is given anywhere from three to six months or longer, depending on other underlying circumstances or cause of the blood clot," said Dr. Jack Ansell, chairman of the department of medicine at Lenox Hill Hospital in New York City. "In Secretary Clinton's case, one would suspect that trauma from her fall played a role. Dehydration, as reported in the news, may also have been a factor. In some patients, there is an underlying hereditary increased tendency to form blood clots, but I am unaware whether this is a factor. Although there is always a risk of recurrence, the risk is very small and most individuals who experience this problem do not have recurrences. A full recovery is expected."

Clinton had been on a strenuous travel schedule in her role as Secretary of State. According to Bloomberg News, the State Department calculates that she has traveled 949,706 miles and visited 112 countries over 401 days -- about 2,084 hours, or nearly 87 days spent airborne.

But Clinton has been less active in recent weeks. On Dec. 9, a day before she was to depart for a trip to North Africa, her staff announced that she had caught a stomach virus and the trip was cancelled. On Dec. 15, Reines issued a statement saying that, "while suffering from a stomach virus, Secretary Clinton became dehydrated and fainted, sustaining a concussion." On Dec. 18, State Department spokeswoman Victoria Nuland said Clinton was "on the mend," and by Dec. 28 Nuland added that Clinton would be returning to work the following week. But the discovery of the clot on Sunday was another health setback.

More information

There's more on blood clots at the U.S. National Library of Medicine.

SOURCES: Anders Cohen, D.O., chief, neurosurgery and spine surgery, The Brooklyn Hospital Center; Jack Ansell, M.D., chairman, department of medicine, Lenox Hill Hospital, New York City; Associated Press; Bloomberg News


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hillary Clintons Hospital Care for Clot Continues
2. Hillary Clinton Has Blood Clot in Head, Full Recovery Expected
3. Neurological Wellness Center Pays Tribute to Newly Released Study Announcing TBI Treatment Breakthrough
4. Rosacea Treatment Concealer Cream Released for Adults by Revitol
5. Dana Point Real Estate Market Forecast 2013 Released by Sam Smith
6. Santiago Canyon Mansion Viral Wedding Film from Pixel Film Studios Released
7. 4W LED Spot Light [ZT-M16G10-411A] is Released by Zhongtian Lighting
8. The Tao Of Badass: Review Examining Joshua Pellicer's Program Released By Vandenhoff Coaching
9. Contemporary Product Solutions Released their Winter Dental Magazine by Evaluating Dental Products and Dental Materials From a "Total Team" Perspective
10. Xoçai™ Activ, A Delicious, Healthy, Active-lifestyle Antioxidant Beverage Has Been Released by Marketing Xocolate International Corporation (MXI Corp)
11. Psoriasis Treatment Cream for Men and Women Released Online by Dermasis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hillary Clinton Released From NYC Hospital
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: